Is Alembic a good stock to invest in?

Alembic can be analyzed on the following key metrics - TTM P/E: 8.14 Sector P/E: 22.04 Dividend Yield: 2.14% D/E ratio: -

Alembic Share Price

Sector: Biotechnology & Drugs

Powered by

112.30 +0.40 (0.36%)

1D
5D
1M
3M
6M
1Y
5Y
MAX

Price Range

Today’s Low 112

Today’s High 113.80

52 Week Low 85.55

52 Week High 169

Key Metrics

Market Cap (In Cr) 2883.66
Beta 1.03
Div. Yield (%) 2.14
P/B 1.23
TTM P/E 8.14
Peg Ratio 0.78
Sector P/E 22.04
D/E 0
Open Price 112.85
Prev Close 111.9

View All Metrics

Alembic Analysis

Price Analysis

1 Week

-1.31%
3 Months

16.66%
6 Month

-19.07%
YTD

-15%
1 Year

10.91%

Risk Meter

45% Low risk
45% Moderate risk
45% Balanced Risk
45% High risk
45% Extreme risk

Alembic News

Stocks to watch: Tata Motors, IndiGo, Nykaa, Vodafone Idea, Coal India among shares in focus today.

Premium

Stocks to watch: Tata Motors, IndiGo, Nykaa, Vi among shares in focus today

2 min read . 02 Jun 2025

Stock market today: According to experts, the short-term trend of the Nifty 50 index remains weak, and the downward correction seems to have gained momentum. (Photo: Pixabay)

Premium

Intraday stocks for today under ₹100: Experts pick five shares to buy or sell

3 min read . 07 Apr 2025

Stock market today: According to experts, a decisive move above the upper range of 22,600 could only open further upside towards 22,800 to 23,000 in the near term. (Photo: PTI)

Premium

Intraday stocks for today under ₹100: Expert recommend 4 stocks to buy today

2 min read . 18 Mar 2025

Stocks to watch: IndusInd Bank, Vedanta, HUL, LIC, Tata Motors among shares to remain in focus today.

Premium

Stocks to watch: IndusInd Bank, Vedanta, HUL, LIC among shares in focus today

2 min read . 18 Mar 2025

View More News

Alembic Financials

INCOME
BALANCE SHEET
Cashflow

DATE

Annual

Quarterly

Period
2025

Total Revenue
221.89

Selling/ General/ Admin Expenses Total
27.31

Depreciation/ Amortization
10.63

Other Operating Expenses Total
31.7

Total Operating Expense
138.8

Operating Income
83.09

Net Income Before Taxes
155.5

Net Income
310.67

Diluted Normalized EPS
12.1

Period
2024

Total Revenue
157.49

Selling/ General/ Admin Expenses Total
45.92

Depreciation/ Amortization
1.7

Other Operating Expenses Total
2.17

Total Operating Expense
108.46

Operating Income
49.02

Net Income Before Taxes
102.69

Net Income
268.62

Diluted Normalized EPS
10.45

Period
2023

Total Revenue
127.24

Selling/ General/ Admin Expenses Total
40.18

Depreciation/ Amortization
1.73

Other Operating Expenses Total
1.71

Total Operating Expense
104.24

Operating Income
23

Net Income Before Taxes
86.8

Net Income
190.65

Diluted Normalized EPS
7.77

Period
2022

Total Revenue
78.22

Selling/ General/ Admin Expenses Total
37.51

Depreciation/ Amortization
1.78

Other Operating Expenses Total
1.7

Total Operating Expense
68.78

Operating Income
9.44

Net Income Before Taxes
97.86

Net Income
222.06

Diluted Normalized EPS
8.57

Period
2021

Total Revenue
73.52

Selling/ General/ Admin Expenses Total
36.58

Depreciation/ Amortization
1.51

Other Operating Expenses Total
1.58

Total Operating Expense
66.39

Operating Income
7.13

Net Income Before Taxes
17.04

Net Income
342.84

Diluted Normalized EPS
13.34

Period
2020

Total Revenue
73.93

Selling/ General/ Admin Expenses Total
35.41

Depreciation/ Amortization
1.28

Other Operating Expenses Total
1.16

Total Operating Expense
73.87

Operating Income
0.05

Net Income Before Taxes
93.17

Net Income
329.12

Diluted Normalized EPS
12.8

Period
2019

Total Revenue
123.81

Selling/ General/ Admin Expenses Total
32.41

Depreciation/ Amortization
1.36

Other Operating Expenses Total
1.34

Total Operating Expense
108.37

Operating Income
15.44

Net Income Before Taxes
44.67

Net Income
213.1

Diluted Normalized EPS
8.29

View detailed financials

Forecast

Income Sheet (In Cr) Net Income Vs Revenue

Returns Metrics (In Cr) ROA Vs ROE

Forecast

Balance Sheet Asset vs Liability

Forecast

Cash Flow Operating vs Investing

Alembic Technical

Moving Average SMA

5 Day111.48
10 Day111.51
20 Day110.02

50 Day104.75
100 Day105.69
300 Day122.52

Alembic Peers

Price
Ratio

Name
Latest Price
Change
% Change
52W High
52W Low
Mkt. Cap

Morepen Laboratories
64.71
-0.45
-0.69
100.8
41.66
3545.81

Advanced Enzyme Technologies
324.5
14.8
4.78
571.15
257.85
3634.06

Alembic
112.3
0.4
0.36
169
85.55
2883.66

Panacea Biotec
440.7
-10
-2.22
581
128.55
2645.32

Gujarat Themis Biosyn
345.15
1.7
0.49
390
192.35
3740.06

Alembic Shareholding

Shareholding Pattern

Shareholding Trend

Shareholding(%) v/s Date

View All

Corporate Actions

Board Meeting
AGM
Dividends
Bonus
Split
Rights

Meeting Date
Purpose

13-May-25
Audited Results & Final Dividend

07-Feb-25
Quarterly Results & Other

08-Nov-24
Quarterly Results & Other

12-Aug-24
Quarterly Results

13-May-24
Audited Results & Final Dividend

14-Feb-24
Quarterly Results

08-Nov-23
Quarterly Results

10-Aug-23
Quarterly Results

12-May-23
Audited Results & Final Dividend

09-Feb-23
Quarterly Results

Meeting Date
Announced on
Purpose

12-Aug-25
13-May-25
AGM

24-Mar-25
19-Feb-25
POM

12-Aug-24
11-Jul-24
AGM

10-Aug-23
12-May-23
AGM

20-Sept-22
10-Aug-22
AGM

23-May-22
19-Apr-22
POM

06-Aug-21
05-Jul-21
AGM

Announced on
Record Date
Ex-Dividend
Dividend Value

13-May-25
-
-
2.4

13-May-24
05-Aug-24
05-Aug-24
2.4

12-May-23
03-Aug-23
03-Aug-23
2.2

05-May-22
13-Sept-22
12-Sept-22
1.8

11-May-21
-
29-Jul-21
0.2

View All

Company Profile

ABOUT Alembic

Industry Biotechnology & Drugs
ISIN INE426A01027
BSE Code 506235
NSE Code ALEMBICLTD

Alembic Limited is an India-based company engaged in the business of development, manufacturing, and marketing of pharmaceutical products. The Company's segments include the Active Pharmaceutical Ingredients Business and the Real Estate Business. The Active Pharmaceutical Ingredients Business is engaged in the manufacturing and marketing of fermentation and chemistry based active pharmaceutical ingredients (API). The Real Estate Business is engaged in the construction of residential and commercial real estate projects and project management and marketing consultancy. The Company provides certain commercial properties on a lease basis to various tenants. The Company is also engaged in research and development activities in Vadodara. It is also engaged in power generation through co-generation.

MANAGEMENT

Malika Amin Chief Executive Officer, Managing Director, Director
Rasesh Shah Chief Financial Officer
Keval Kumar Thakkar Chief Compliance Officer, Company Secretary

ALEMBIC SUMMARY

Alembic is trading 0.36% upper at Rs 112.30 as compared to its last closing price. Alembic has been trading in the price range of 113.80 & 112. Alembic has given -15% in this year & -1.31% in the last 5 days.

Alembic has TTM P/E ratio 8.14 as compared to the sector P/E of 22.04.

The company posted a net profit of 68.45 Crores in its last quarter.

Listed peers of Alembic include Morepen Laboratories (-0.69%), Advanced Enzyme Technologies (4.78%), Alembic (0.36%) etc.

Alembic has a 70.88% promoter holding & 29.12% public holding.

FAQs about Alembic

Alembic is trading at 112.30 as on 10 Jun, 2025 3:45:45 PM. This is 0.36% upper as compared to its previous closing price of 111.9

The market capitalization of Alembic is 2883.66 Cr as on 10 Jun, 2025 3:45:45 PM.

The 52 wk high for Alembic is 169 whereas the 52 wk low is 85.55

Alembic can be analyzed on the following key metrics -

TTM P/E: 8.14
Sector P/E: 22.04
Dividend Yield: 2.14%
D/E ratio: -

Alembic reported a net profit of 310.67 Cr in 2025.

Alembic Quick Links

Equity Quick Links

Top Gainers | Top Losers | Indian Indices | BSE Active Stocks | NSE Active Stocks

Alembic Share Price

Price Range

Price Range

Key Metrics

Alembic Analysis

Alembic News

Stocks to watch: Tata Motors, IndiGo, Nykaa, Vi among shares in focus today

Intraday stocks for today under ₹100: Experts pick five shares to buy or sell

Intraday stocks for today under ₹100: Expert recommend 4 stocks to buy today

Stocks to watch: IndusInd Bank, Vedanta, HUL, LIC among shares in focus today

Alembic Financials

Forecast

Forecast

Forecast

Alembic Technical

Alembic Peers

Alembic Shareholding

Shareholding Pattern

Shareholding Trend

Corporate Actions

Company Profile

ABOUT Alembic

MANAGEMENT

ALEMBIC SUMMARY

FAQs about Alembic

Wait for it…

Wait for it…

Congratulations!

Subscribe to continue